This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
The shrimp species changes the clinical question
The WOAH manual describes acute, potentially devastating disease in susceptible unselected blue shrimp populations, Penaeus stylirostris. Young shrimp can be particularly vulnerable. That history should not be converted into a prediction that every infected shrimp species will experience the same mortality.
Whiteleg shrimp, Penaeus vannamei, more commonly develop a chronic problem described as runt-deformity syndrome. Deaths can be limited even when growth and uniformity suffer. Selected lines and different virus populations can also differ in outcome.
Identify the species and source population at the beginning of an investigation. The words shrimp and prawn are used inconsistently in commerce; a common product label alone may not establish which biological evidence applies.
Recognizing runt-deformity syndrome
Poor growth, uneven sizes and a bent or otherwise deformed rostrum can raise suspicion. The abdomen, shell or appendages may also appear abnormal. Affected whiteleg shrimp can remain in the crop for a prolonged period, so the practical loss may be a disappointing harvest rather than a sudden mortality event.
The Canadian Food Inspection Agency fact sheet also describes poor feed conversion and the possibility of infection without visible signs. Selecting only attractive, large animals for inspection can therefore give a misleading picture of a batch.
Deformity is not uniquely diagnostic. Injury, abnormal development, nutritional problems and other health conditions require consideration. EHP is another reason to investigate poor growth, but it is a different organism with a different principal tissue target.
Acute illness still requires an urgent response
In an affected susceptible population, feeding can fall, swimming may become abnormal and losses can rise rapidly. Weak shrimp at the surface are an immediate welfare and production concern, regardless of the eventual diagnosis.
Check aeration, oxygen and recent water-system changes while contacting an aquatic veterinarian or competent authority. Acute water-quality failure can occur alongside infection and should not be ignored while waiting for a test report.
Avoid transferring apparently healthy survivors to another unit. They may have shared the exposure or carry infection without obvious illness. A different appearance does not establish a different infection status.
Why a positive PCR result needs interpretation
Some shrimp, notably certain giant tiger prawn populations, contain IHHNV-related sequences integrated into their own genome. A molecular assay that detects such a sequence may not demonstrate an actively replicating infectious virus. WOAH addresses this complication in its disease and diagnostic guidance.
This is not a reason to dismiss every positive finding. The appropriate question is whether the laboratory method distinguishes the relevant target and whether additional evidence is needed. Ask the diagnostic service how it interprets the result for this species and the purpose of testing.
Screening apparently healthy seed, confirming disease in sick animals and evaluating freedom from infection are different tasks. A test can be useful for one purpose without justifying every claim about the whole production site. Leave assay selection and confirmation to an experienced laboratory rather than comparing isolated numbers from unrelated test reports.
Carriers matter even when mortality is low
Infected survivors can transmit infection to other shrimp and, in some circumstances, to their offspring. Contaminated water and consumption of infected shrimp are also relevant routes. These connections explain why low mortality is not equivalent to low biosecurity importance.
Review broodstock and seed sourcing as well as recent movements between ponds or tanks. A contained recirculating facility still depends on the health of the animals entering it. Physical containment alone cannot establish that a seed batch is free of a pathogen.
Separate equipment and handling between populations under investigation. Do not use suspect stock, carcasses or processing waste as feed or bait. A product intended for human consumption has not necessarily been assessed for safe introduction into an aquatic production environment.
Treatment and production decisions
CFIA describes no established treatment option for IHHN. Antibiotics do not clear a viral infection, and an improved growth rate after a husbandry change does not prove that the population is now free of IHHNV.
Support good oxygen conditions, suitable nutrition and a stable environment for remaining shrimp. Avoid intensive handling that adds stress or moves contaminated water between units. The health team can help distinguish a manageable chronic production problem from an acute event or a regulated introduction requiring wider action.
Do not assume that a virus with no recognized human disease risk makes every affected product acceptable for sale. Animal-health movement restrictions, lawful harvest decisions and ordinary food-safety requirements are separate considerations. Obtain advice relevant to the destination and product.
Prevent introduction rather than relying on appearance
Use disease-screened seed and broodstock from an appropriate health program. Ask specifically whether IHHNV is included, which population was assessed and whether the certificate covers the delivered batch. “Specific pathogen free” refers to named pathogens within a defined program, not freedom from every possible infection.
Where resistant or tolerant stock is available, understand the claim. Better survival or performance does not necessarily mean inability to become infected or transmit virus. Genetics complements exclusion and husbandry; it does not replace them.
The shrimp farming page links these choices to hatchery seed, feed and pond management. After a confirmed finding, agree on cleaning, stock movement and restocking with the relevant aquatic-health service. The aim is a sound next-crop decision based on the actual infection, rather than treating a bent rostrum or a single test value in isolation.
Cite this reference
LivestockDefense. “IHHNV in shrimp: runt-deformity syndrome, species differences and testing.” Updated 2026-11-02. https://livestockdefense.com/threats/infectious-hypodermal-hematopoietic-necrosis-shrimp/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- World Organisation for Animal Health: Infection with infectious hypodermal and haematopoietic necrosis virus: Aquatic Manual chapter 2.2.4
Source update: Not provided. Most recent check: 2026-11-02.
Species/population differences in acute disease versus runt-deformity syndrome; carriers and transmission; endogenous viral sequences complicate some molecular interpretation. No pathogen-handling method or experimental heating recommendation.
- Canadian Food Inspection Agency: Infectious hypodermal and haematopoitic necrosis: fact sheet
Source update: Not provided. Most recent check: 2026-11-02.
Different shrimp clinical patterns, asymptomatic transmission, laboratory confirmation, absence of established treatment and movement/equipment biosecurity. Canadian reporting status is not generalized internationally.
- Australian Government Department of Agriculture, Fisheries and Forestry: Review of prawns and prawn products: final report summary
Source update: Not provided. Most recent check: 2026-11-02.
Current official risk-review landing text identifies multiple distinct agents and product/exposure-specific biosecurity concerns; proposed measures not described as enacted universal law.
